I agree that this site is using cookies. You can find further informations here.
X
Antignani, Gabriella
30  results:
Search for persons X
?
1

Low-dose decitabine enhances the efficacy of viral cancer v..:

Russo, Salvatore ; Feola, Sara ; Feodoroff, Michaela...
Molecular Therapy: Oncology.  32 (2024)  1 - p. 200766 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Hybrid eumelanin/graphene-like/TiO2 bio-interface for mouse..:

Amantea, Francesca ; Antignani, Gabriella ; Pota, Giulio...
Applied Surface Science.  633 (2023)  - p. 157608 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 i..:

Hamdan, Firas ; Feodoroff, Michaela ; Russo, Salvatore...
Molecular Therapy - Oncolytics.  28 (2023)  - p. 264-276 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Development of mesothelioma-specific oncolytic immunotherap..:

Chiaro, Jacopo ; Antignani, Gabriella ; Feola, Sara...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
5

Peptides-Coated Oncolytic Vaccines for Cancer Personalized ..:

Feola, Sara ; Russo, Salvatore ; Martins, Beatriz...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
6

A novel immunopeptidomic-based pipeline for the generation ..:

Feola, Sara ; Chiaro, Jacopo ; Martins, Beatriz...
eLife.  11 (2022)  - p. , 2022
Link: https://doi.org/10.7554/..
 
?
7

GAMER-Ad: a novel and rapid method for generating recombina..:

Hamdan, Firas ; Martins, Beatriz ; Feodoroff, Michaela...
Molecular Therapy - Methods & Clinical Development.  20 (2021)  - p. 625-634 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Novel oncolytic adenovirus expressing enhanced cross-hybrid..:

Hamdan, Firas ; Ylösmäki, Erkko ; Chiaro, Jacopo...
Journal for ImmunoTherapy of Cancer.  9 (2021)  8 - p. e003000 , 2021
Link: https://doi.org/10.1136/..
 
?
9

PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landsc..:

Feola, Sara ; Haapala, Markus ; Peltonen, Karita...
ACS Nano.  15 (2021)  10 - p. 15992-16010 , 2021
Link: https://doi.org/10.1021/..
 
?
10

Development of mesothelioma-specific oncolytic immunotherap..:

Chiaro, Jacopo ; Antignani, Gabriella ; Feola, Sara...
10.1038/s41467-023-42668-7.  , 2024
Link: http://hdl.handle.net/10..
 
?
11

Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 i..:

Hamdan, Firas ; Feodoroff, Michaela ; Russo, Salvatore...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995465/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Controlled release of enhanced cross-hybrid IgGA Fc PD-L1 i..:

Hamdan, Firas ; Feodoroff, Michaela ; Russo, Salvatore...
10.1016/j.omto.2023.01.006.  , 2023
Link: http://hdl.handle.net/10..
 
?
13

Development of mesothelioma-specific oncolytic immunotherap..:

Chiaro, Jacopo ; Antignani, Gabriella ; Feola, Sara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624665/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Peptides-Coated Oncolytic Vaccines for Cancer Personalized ..:

Feola, Sara ; Russo, Salvatore ; Martins, Beatriz...
boreal:279320.  , 2022
Link: http://hdl.handle.net/20..
 
?
15

Patient-Derived Organoids for Precision Cancer Immunotherap:

Grönholm, Mikaela ; Feodoroff, Michaela Josefine ; Antignani, Gabriella...
10.1158/0008-5472.CAN-20-4026.  , 2022
Link: http://hdl.handle.net/10..
 
1-15